Closed Solicitation · DEPARTMENT OF HEALTH AND HUMAN SERVICES
AI Summary
The National Institutes of Health intends to award a non-competitive contract for Oxford Nanopore sequencing reagents, essential for high-throughput DNA sequencing. This acquisition falls under FAR Part 13 Simplified Acquisition Procedures and is crucial for supporting ongoing genomic research across multiple laboratories. Interested parties may submit their capabilities by July 27, 2026.
General Information Document Type: Presolicitation Synopsis Number: 75N98026Q00696 Posted Date: July 16, 2026 Original Response Date: July 27, 2026 Current Response Date: July 27, 2026 Set Aside: N/A NAICS Code: 541713 Contracting Office Address National Institutes of Health (NIH), Office of the Director (OD) Office of Logistics and Operations (OLAO) Office of Acquisition and Logistics Management (OALM) Hospital and Laboratory Support Division 6701 Rockledge Drive Bethesda, MD 20817 Description INTRODUCTION THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME). The National Institutes of Health (NIH) intends to negotiate and award a contract without providing for full and open competition (Including brand-name) to: Oxford Nanopore Technologies Inc. 101 Avenue of the Americas New York 10013 NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE The intended procurement is classified under NAICS code 541713 with a Size Standard $1000. REGULATORY AUTHORITY The resultant contract will include all applicable provisions and clauses in effect through the Federal Acquisition Circular (FAC) 2026-01, March 13, 2026. This acquisition is conducted under the procedures as prescribed in FAR subpart 13-Simplified Acquisition Procedures at an amount not exceeding the simplified acquisition threshold ($350,000). STATUTORY AUTHORITY This acquisition is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13-Simplified Acquisition Procedures, Subpart 13.106-1 (b) (1), Soliciting from a single source and is not expected to exceed the simplified acquisition threshold. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements. GENERAL INFORMATION Title: Oxford Nanopore Sequencing Reagents Background Information: The NIH Intramural Sequencing Center (NISC) is a centralized research facility for performing high-throughput, large-scale DNA sequencing and sequence analysis. Nanopore-based sequencing is a new technology that is fast emerging for its unique ability to produce extremely long reads, exceeding 100 kb. This is very powerful for DNA sequence assembly in repeat regions and for determining haplotypes. NISC is working with investigators who are trying to complete unresolved regions of the human genome. For this work extremely long reads that only this technology can currently provide are required. NISC requires reagents to meet sequencing demands on this platform. NISC directly supports >50 laboratories across >10 ICs by processing thousands of samples annually for highly specialized sequencing analysis and purchase of these reagents will continue to support these ongoing studies. Failure to purchase these reagents will compromise the ability of NISC to support intramural research. These reagents are available on GSA Schedule GS-07F-5934R, Sin # 334516 through Government Scientific Source, Inc.. CLOSING STATEMENT This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include a technical proposal, a cost-price proposal, the period of performance, the Unique Entity ID (UEI), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement. All responses must be received by July 27, 2026 at 9:00 AM Eastern time and must reference solicitation number 75N98026Q00696. Responses may be submitted electronically to Mr. James Law, Contracting Officer at James.Law@nih.gov. Fax responses will not be accepted. "All responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency.
Oxford Nanopore Sequencing Reagents is a federal acquisition solicitation issued by DEPARTMENT OF HEALTH AND HUMAN SERVICES. Review the full description, attachments, and submission requirements on SamSearch before the response deadline.
SamSearch Platform
AI-powered intelligence for the right opportunities, the right leads, and the right time.